← Back to patent-cliff list
Dyclonine hydrochloride
Tier C — Watch / tradeDyclonine hydrochloride
AstraZeneca
Originator
1995
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Brand：Dyclone
Indications (approved)：Pruritus, Pain
Regional status
US
Withdrawn
EU
-
China
Approved
1995-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Dyclonine hydrochloride?
Approved indications include: Pruritus, Pain.
When does the Dyclonine hydrochloride patent expire?
No public expiry year is available for Dyclonine hydrochloride yet; this page updates once verified.
How do I get a quote for Dyclonine hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04